vs

Side-by-side financial comparison of REGIS CORP (RGS) and SI-BONE, Inc. (SIBN). Click either name above to swap in a different company.

REGIS CORP is the larger business by last-quarter revenue ($57.1M vs $56.3M, roughly 1.0× SI-BONE, Inc.). REGIS CORP runs the higher net margin — 0.8% vs -2.9%, a 3.7% gap on every dollar of revenue. On growth, REGIS CORP posted the faster year-over-year revenue change (22.3% vs 15.0%). REGIS CORP produced more free cash flow last quarter ($891.0K vs $440.0K). Over the past eight quarters, SI-BONE, Inc.'s revenue compounded faster (22.0% CAGR vs 7.8%).

Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.

Bone Clones, Inc. manufactures, distributes, and sells osteological reproductions of human and animal bones. Located in Chatsworth, California, Bone Clones provides these reproductions to museums, universities, medical schools, and other educational institutions.

RGS vs SIBN — Head-to-Head

Bigger by revenue
RGS
RGS
1.0× larger
RGS
$57.1M
$56.3M
SIBN
Growing faster (revenue YoY)
RGS
RGS
+7.3% gap
RGS
22.3%
15.0%
SIBN
Higher net margin
RGS
RGS
3.7% more per $
RGS
0.8%
-2.9%
SIBN
More free cash flow
RGS
RGS
$451.0K more FCF
RGS
$891.0K
$440.0K
SIBN
Faster 2-yr revenue CAGR
SIBN
SIBN
Annualised
SIBN
22.0%
7.8%
RGS

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
RGS
RGS
SIBN
SIBN
Revenue
$57.1M
$56.3M
Net Profit
$456.0K
$-1.6M
Gross Margin
79.0%
Operating Margin
10.8%
-4.4%
Net Margin
0.8%
-2.9%
Revenue YoY
22.3%
15.0%
Net Profit YoY
-94.0%
63.4%
EPS (diluted)
$0.16
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RGS
RGS
SIBN
SIBN
Q4 25
$57.1M
$56.3M
Q3 25
$59.0M
$48.7M
Q2 25
$60.4M
$48.6M
Q1 25
$57.0M
$47.3M
Q4 24
$46.7M
$49.0M
Q3 24
$46.1M
$40.3M
Q2 24
$49.4M
$40.0M
Q1 24
$49.2M
$37.9M
Net Profit
RGS
RGS
SIBN
SIBN
Q4 25
$456.0K
$-1.6M
Q3 25
$1.4M
$-4.6M
Q2 25
$116.5M
$-6.2M
Q1 25
$250.0K
$-6.5M
Q4 24
$7.6M
$-4.5M
Q3 24
$-853.0K
$-6.6M
Q2 24
$91.2M
$-8.9M
Q1 24
$-2.3M
$-10.9M
Gross Margin
RGS
RGS
SIBN
SIBN
Q4 25
79.0%
Q3 25
79.8%
Q2 25
79.8%
Q1 25
79.7%
Q4 24
79.1%
Q3 24
79.1%
Q2 24
79.0%
Q1 24
78.9%
Operating Margin
RGS
RGS
SIBN
SIBN
Q4 25
10.8%
-4.4%
Q3 25
10.0%
-11.1%
Q2 25
12.1%
-14.4%
Q1 25
8.8%
-15.8%
Q4 24
11.8%
-11.2%
Q3 24
4.6%
-18.9%
Q2 24
-25.2%
Q1 24
8.3%
-31.8%
Net Margin
RGS
RGS
SIBN
SIBN
Q4 25
0.8%
-2.9%
Q3 25
2.3%
-9.4%
Q2 25
192.9%
-12.7%
Q1 25
0.4%
-13.8%
Q4 24
16.4%
-9.2%
Q3 24
-1.9%
-16.3%
Q2 24
184.7%
-22.4%
Q1 24
-4.7%
-28.8%
EPS (diluted)
RGS
RGS
SIBN
SIBN
Q4 25
$0.16
$-0.04
Q3 25
$0.49
$-0.11
Q2 25
$43.67
$-0.14
Q1 25
$0.08
$-0.15
Q4 24
$2.71
$-0.10
Q3 24
$-0.36
$-0.16
Q2 24
$38.40
$-0.22
Q1 24
$-1.00
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RGS
RGS
SIBN
SIBN
Cash + ST InvestmentsLiquidity on hand
$18.4M
$42.2M
Total DebtLower is stronger
$113.3M
$35.6M
Stockholders' EquityBook value
$188.7M
$177.5M
Total Assets
$588.3M
$238.6M
Debt / EquityLower = less leverage
0.60×
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RGS
RGS
SIBN
SIBN
Q4 25
$18.4M
$42.2M
Q3 25
$16.6M
$26.5M
Q2 25
$17.0M
$34.1M
Q1 25
$13.3M
$41.2M
Q4 24
$10.2M
$34.9M
Q3 24
$6.3M
$30.2M
Q2 24
$10.1M
$25.6M
Q1 24
$5.9M
$32.0M
Total Debt
RGS
RGS
SIBN
SIBN
Q4 25
$113.3M
$35.6M
Q3 25
$111.3M
$35.5M
Q2 25
$110.8M
$35.5M
Q1 25
$112.0M
$35.5M
Q4 24
$111.5M
$35.5M
Q3 24
$95.2M
$36.2M
Q2 24
$99.5M
$36.1M
Q1 24
$179.7M
$36.1M
Stockholders' Equity
RGS
RGS
SIBN
SIBN
Q4 25
$188.7M
$177.5M
Q3 25
$187.6M
$172.1M
Q2 25
$185.6M
$170.3M
Q1 25
$68.6M
$167.3M
Q4 24
$66.7M
$167.0M
Q3 24
$56.4M
$165.0M
Q2 24
$56.8M
$164.7M
Q1 24
$-35.8M
$165.5M
Total Assets
RGS
RGS
SIBN
SIBN
Q4 25
$588.3M
$238.6M
Q3 25
$592.1M
$234.3M
Q2 25
$599.0M
$230.9M
Q1 25
$511.2M
$227.3M
Q4 24
$530.1M
$230.4M
Q3 24
$508.9M
$227.0M
Q2 24
$530.5M
$223.8M
Q1 24
$543.7M
$223.7M
Debt / Equity
RGS
RGS
SIBN
SIBN
Q4 25
0.60×
0.20×
Q3 25
0.59×
0.21×
Q2 25
0.60×
0.21×
Q1 25
1.63×
0.21×
Q4 24
1.67×
0.21×
Q3 24
1.69×
0.22×
Q2 24
1.75×
0.22×
Q1 24
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RGS
RGS
SIBN
SIBN
Operating Cash FlowLast quarter
$1.7M
$1.7M
Free Cash FlowOCF − Capex
$891.0K
$440.0K
FCF MarginFCF / Revenue
1.6%
0.8%
Capex IntensityCapex / Revenue
1.4%
2.3%
Cash ConversionOCF / Net Profit
3.65×
TTM Free Cash FlowTrailing 4 quarters
$14.9M
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RGS
RGS
SIBN
SIBN
Q4 25
$1.7M
$1.7M
Q3 25
$2.3M
$2.3M
Q2 25
$6.8M
$173.0K
Q1 25
$6.2M
$-4.9M
Q4 24
$2.1M
$1.2M
Q3 24
$-1.3M
$302.0K
Q2 24
$5.1M
$-6.3M
Q1 24
$-277.0K
$-7.6M
Free Cash Flow
RGS
RGS
SIBN
SIBN
Q4 25
$891.0K
$440.0K
Q3 25
$1.9M
$-620.0K
Q2 25
$6.2M
$-1.9M
Q1 25
$5.9M
$-7.0M
Q4 24
$1.7M
$-1.1M
Q3 24
$-1.4M
$-2.7M
Q2 24
$5.1M
$-9.4M
Q1 24
$-326.0K
$-9.7M
FCF Margin
RGS
RGS
SIBN
SIBN
Q4 25
1.6%
0.8%
Q3 25
3.2%
-1.3%
Q2 25
10.3%
-4.0%
Q1 25
10.3%
-14.8%
Q4 24
3.6%
-2.2%
Q3 24
-3.0%
-6.8%
Q2 24
10.3%
-23.6%
Q1 24
-0.7%
-25.5%
Capex Intensity
RGS
RGS
SIBN
SIBN
Q4 25
1.4%
2.3%
Q3 25
0.7%
6.1%
Q2 25
0.9%
4.3%
Q1 25
0.6%
4.4%
Q4 24
0.9%
4.6%
Q3 24
0.0%
7.5%
Q2 24
0.0%
7.8%
Q1 24
0.1%
5.5%
Cash Conversion
RGS
RGS
SIBN
SIBN
Q4 25
3.65×
Q3 25
1.68×
Q2 25
0.06×
Q1 25
24.80×
Q4 24
0.28×
Q3 24
Q2 24
0.06×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RGS
RGS

Franchise Segment$37.9M66%
Royalty$13.6M24%
Other$2.8M5%
Fees$1.8M3%
Franchise Fees$1.0M2%

SIBN
SIBN

US$53.5M95%
Non Us$2.9M5%

Related Comparisons